Hypoxia is frequently observed during tumor progression, which, in turn, leads to cancer cells starting to secrete immunosuppressive cytokines such as vascular endothelial growth factor (VEGF) and transforming growth factor β (TGF-β) [1,2]. Here, VEGFA is linked to cancer.